The American Gastroenterological Association provides best practice advice to assist gastroenterologists in making an accurate diagnosis and providing optimal treatment for patients with colonic diverticulitis.
Despite numerous studies showing a potential association between celiac disease and small bowel cancer, there is a lack of data evaluating the risk of specific subtypes of small bowel cancer.
A team of investigators from the Mayo Clinic sought to determine whether colonization of C difficile in the colon may contribute to infection recurrence following antibiotic treatment.
Investigators assessed the predictive capacity and diagnostic yield of a minimum 10-fold increase in serum IgA antitissue transglutaminase antibody levels in celiac disease.
Investigators compared sigmoid resection with conservative treatment to ascertain which intervention most effectively improved quality of life for patients with recurrent, complicated, or persistent painful diverticulitis.
Investigators characterized the gut microbiota of children with celiac disease to collect data on the determinants of the microbiota likely to change in children following a gluten-free diet.
The American Gastroenterological Association provides updated guidance for the diagnosis and management of gastrointestinal and hepatic toxicities associated with immunotherapy use.
Investigators evaluated the prevalence of small intestinal bacterial overgrowth (SIBO) in a well-defined cohort of patients with functional dyspepsia (FD) using quantitative microbiological assessment of the duodenal aspirate.
Metronidazole, vancomycin, fidaxomicin, meropenem, and piperacillin/tazobactam are rarely resistant to Clostridioides (Clostridium) difficile infection, while second-generation fluoroquinolones and clindamycin show highest risk.
Investigators sought to evaluate the role of breast milk immunoglobulin A (IgA) in norovirus (NV) infection and diarrhea in infants to determine whether breast milk IgA has a preventive effect against NV infection and subsequent diarrhea.
To improve the assessment and management of patients with seronegative enteropathies, the AGA reviewed studies that reported on the management of patients with suspected celiac disease or other enteropathies not related to gluten who had received negative results from serologic tests.
Emerging evidence indicates that gastrointestinal and hepatic manifestations may play an important role in COVID-19, but their prevalence and significance remain unknown.
